Literature DB >> 15120607

Interference of hepatitis A virus replication by small interfering RNAs.

Tatsuo Kanda1, Yuri Kusov, Osamu Yokosuka, Verena Gauss-Müller.   

Abstract

The rate of acute liver failure due to hepatitis A virus (HAV) has not decreased, and therapy of severe infections is still of major interest. Using a DNA-based HAV replicon cell culture system, we demonstrate that small interfering RNAs (siRNAs) targeted against viral sequences or a reporter gene contained in the viral genome specifically inhibit HAV RNA replication in HuhT7 cells. Combinations of siRNAs were more effective suppressors of HAV RNA replication. Also, siRNAs targeted against HAV 2C and 3D inhibited the expression of the respective protein. Expressions of endogenous beta-actin and double-stranded-specific RNA-activated serin/threonine kinase (PKR) were unaltered, demonstrating that the siRNA inhibitory effect was not connected to interferon inhibition, but rather was specifically targeted against HAV RNA. These results suggest that RNA interference might ultimately be useful in treatment of severe HAV infection with or without chronic liver diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15120607     DOI: 10.1016/j.bbrc.2004.03.194

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  RNA interference against animal viruses: how morbilliviruses generate extended diversity to escape small interfering RNA control.

Authors:  Carine L Holz; Emmanuel Albina; Cécile Minet; Renaud Lancelot; Olivier Kwiatek; Geneviève Libeau; Renata Servan de Almeida
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Silencing of hepatitis A virus infection by small interfering RNAs.

Authors:  Yuri Kusov; Tatsuo Kanda; Ann Palmenberg; Jean-Yves Sgro; Verena Gauss-Müller
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

3.  A small interfering RNA targeting coxsackievirus B3 protects permissive HeLa cells from viral challenge.

Authors:  Jeonghyun Ahn; Eun Seok Jun; Hui Sun Lee; Seung Yong Yoon; DongHou Kim; Chul-Hyun Joo; Yoo Kyum Kim; Heuiran Lee
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs.

Authors:  Susan L Uprichard; Bryan Boyd; Alana Althage; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-07       Impact factor: 11.205

5.  Combination of small interfering RNAs mediates greater inhibition of human hepatitis B virus replication and antigen expression.

Authors:  Zhe Chen; Ze-feng Xu; Jing-jia Ye; Hang-ping Yao; Shu Zheng; Jia-yi Ding
Journal:  J Zhejiang Univ Sci B       Date:  2005-04       Impact factor: 3.066

6.  Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha.

Authors:  Lingli Yang; Tomoko Kiyohara; Tatsuo Kanda; Fumio Imazeki; Keiichi Fujiwara; Verena Gauss-Müller; Koji Ishii; Takaji Wakita; Osamu Yokosuka
Journal:  Virol J       Date:  2010-09-03       Impact factor: 4.099

7.  Hepatitis A virus-encoded miRNAs attenuate the accumulation of viral genomic RNAs in infected cells.

Authors:  Jiandong Shi; Jing Sun; Meini Wu; Ningzhu Hu; Yunzhang Hu
Journal:  Virus Genes       Date:  2016-03-02       Impact factor: 2.332

8.  Controllable inhibition of hepatitis B virus replication by a DR1-targeting short hairpin RNA (shRNA) expressed from a DOX-inducible lentiviral vector.

Authors:  Weiwei Wang; Hongquan Peng; Jiafu Li; Xiping Zhao; Fei Zhao; Kanghong Hu
Journal:  Virus Genes       Date:  2013-02-09       Impact factor: 2.332

9.  Inhibition of highly pathogenic PRRSV replication in MARC-145 cells by artificial microRNAs.

Authors:  Shuqi Xiao; Qiwei Wang; Jintao Gao; Liangliang Wang; Zuyong He; Delin Mo; Xiaohong Liu; Yaosheng Chen
Journal:  Virol J       Date:  2011-11-01       Impact factor: 4.099

10.  Suppression of La antigen exerts potential antiviral effects against hepatitis A virus.

Authors:  Xia Jiang; Tatsuo Kanda; Shuang Wu; Shingo Nakamoto; Kengo Saito; Hiroshi Shirasawa; Tomoko Kiyohara; Koji Ishii; Takaji Wakita; Hiroaki Okamoto; Osamu Yokosuka
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.